Guidelines Formulated for Arterial Conduits in CABG

This article originally appeared here.
Share this content:
Guidelines Formulated for Arterial Conduits in CABG
Guidelines Formulated for Arterial Conduits in CABG

WEDNESDAY, Dec. 9, 2015 (HealthDay News) -- Guidelines have been formulated for arterial conduits for coronary artery bypass graft (CABG) surgery, and published online Dec. 8 in the Annals of Thoracic Surgery.

Gabriel S. Aldea, M.D., from the University of Washington School of Medicine in Seattle, and colleagues reviewed the literature to formulate recommendations relating to use of arterial and venous conduits in CABG procedures.

The researchers note that when bypass of left anterior descending (LAD) artery is indicated, internal thoracic arteries (ITAs) should be used for bypass. A second arterial graft should be considered in appropriate patients as an adjunct to left ITA. In patients who do not have an excessive risk of sternal complications, use of bilateral ITAs should be considered. In order to reduce the risk of sternal infection with bilateral ITA, skeletonized grafts and glycemic control should be considered, smoking cessation is recommended, and enhanced sternal stabilization may be considered. Use of a radial artery graft is reasonable when grafting coronary targets with severe stenoses as an adjunct to left ITA or LAD. Pharmacologic agent use is reasonable to reduce acute intraoperative and perioperative spasm when radial artery grafts are used. In patients with poor conduit options the right gastroepiploic artery may be considered.

"We recommend discussing treatment options with the heart team to determine the most effective graft conduit for each individual patient," Aldea said in a statement.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »